양성자 치료 시스템 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Proton Therapy Systems Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

US $ 4,995 ￦ 6,944,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,142,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,810,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

이 보고서는 세계 양성자 치료 시스템 시장을 조사 분석하여 시장 촉진요인, 동향, 기회, 촉진요인, 도전 과제 등 주요 시장 역학에 대한 평가와 시장 구조에 대한 상세한 인사이트를 제공합니다.

목차

제1장 주요 요약

제2장 시장 소개

제3장 세계의 양성자 치료 시장 분석 시나리오

• 시장과 예측
  • 시장 규모와 전년비 성장

제4장 시장 역학

• 경제적 요인
• 성장 촉진요인
  • 공급측
  • 수요측
• 성장 억제요인
• 기회
• 가동 대수 데이터
• 세계의 암 유병률

제5장 세계의 양성자 치료 시장 분석과 예측 : 셋업 유형별

• 소개
• BPS(Basis Point Share) 분석 : 셋업 유형별
• 전년비 성장 예측 : 셋업 유형별
• 시장 금액 예측 : 셋업 유형별
  • 싱글 룸
  • 멀티 룸
• 시장 매력 : 셋업 유형별

제6장 세계의 양성자 치료 시장 분석과 예측 : 적응증별

• 소개
• BPS(Basis Point Share) 분석 : 적응증별
• 전년비 성장 예측 : 적응증별
• 시장 금액 예측 : 적응증별
  • 두경부암
  • 뇌종양
  • 육종
  • 소아암
  • 소화기암
  • 전립선암
  • 폐암
• 시장 매력 : 적응증별

제7장 세계의 양성자 치료 시장 분석과 예측 : 지역별

• BPS(Basis Point Share) 분석 : 지역별
• 전년비 성장 예측 : 지역별
• 시장 금액 예측 : 지역별
  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
• 시장 매력 : 지역별

제8장 북미의 양성자 치료 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
• 시장 금액 예측 : 셋업 유형별
  • 싱글 룸
  • 멀티 룸
• 시장 금액 예측 : 적응증별
  • 두경부암
  • 뇌종양
  • 육종
  • 소아암
  • 소화기암
  • 전립선암
  • 폐암
• 시장 금액 예측 : 국가별
  • 미국
• 시장 매력 분석
  • 셋업 유형별
  • 적응증별

제9장 유럽의 양성자 치료 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
• 시장 금액 예측 : 셋업 유형별
  • 싱글 룸
  • 멀티 룸
• 시장 금액 예측 : 적응증별
  • 두경부암
  • 뇌종양
  • 육종
  • 소아암
  • 소화기암
  • 전립선암
  • 폐암
• 시장 금액 예측 : 국가별
  • 프라하
  • 프랑스
  • 스위스
  • 이탈리아
  • 독일
  • 영국
  • 스웨덴
  • 러시아
• 시장 매력 분석
  • 셋업 유형별
  • 적응증별
  • 국가별

제10장 아시아태평양의 양성자 치료 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석 : 국가별
  • 전년비 성장 예측 : 국가별
• 시장 금액 예측 : 셋업 유형별
  • 싱글 룸
  • 멀티 룸
• 시장 금액 예측 : 적응증별
  • 두경부암
  • 뇌종양
  • 육종
  • 소아암
  • 소화기암
  • 전립선암
  • 폐암
• 시장 금액 예측 : 국가별
  • 중국
  • 일본
  • 한국
• 시장 매력 분석
  • 셋업 유형별
  • 적응증별
  • 국가별

제11장 중동 및 아프리카의 양성자 치료 시장 분석과 예측

• 소개
  • BPS(Basis Point Share) 분석
  • 전년비 성장 예측
• 시장 금액 예측 : 셋업 유형별
  • 싱글 룸
  • 멀티 룸
• 시장 금액 예측 : 적응증별
  • 두경부암
  • 뇌종양
  • 육종
  • 소아암
  • 소화기암
  • 전립선암
  • 폐암
• 시장 금액 예측 : 국가별
  • 남아프리카공화국
• 시장 매력 분석
  • 셋업 유형별
  • 적응증별

제12장 경쟁 상황

• 경쟁 대시보드
• 기업 개요(상세 - 개요, 재무, 전략, 최근의 동향)
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTom International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems

제13장 사용되는 가정과 두문자어

제14장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Proton Therapy Systems market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

• Proton Therapy Systems Market Size (2024E): USD 719.7 Mn
• Projected Market Value (2031F): USD 1581.1 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 11.9%

Proton Therapy Systems Market - Report Scope:

Proton Therapy is an advanced form of radiation therapy used primarily in the treatment of cancer. It uses protons rather than X-rays to target tumors with precision, minimizing damage to surrounding healthy tissues. This technology is especially beneficial for treating complex cancer cases, including pediatric cancers and tumors located in sensitive areas. The Proton Therapy Systems market includes healthcare facilities, research institutes, and specialized cancer treatment centers globally. Market growth is driven by the rising prevalence of cancer, increasing adoption of advanced radiation therapy techniques, and a growing emphasis on personalized treatment approaches.

Market Growth Drivers:

The global Proton Therapy Systems market is driven by a range of critical factors. Rising incidences of cancer worldwide, coupled with the increasing focus on personalized healthcare, have heightened the demand for precision treatment solutions like proton therapy. As proton therapy significantly reduces the risk of radiation exposure to non-cancerous tissues, it is favored for treating pediatric cancers and complex cases involving sensitive organs. Government initiatives and funding for cancer research, along with advancements in proton therapy technology, such as pencil-beam scanning, enhance treatment precision and widen the applicability of these systems. Furthermore, the expansion of healthcare infrastructure in emerging economies has contributed to increased accessibility and demand for proton therapy systems.

Market Restraints:

Despite promising growth prospects, the Proton Therapy Systems market faces significant challenges. High initial investment costs and the requirement for specialized infrastructure limit the adoption of proton therapy, particularly in low-income regions. The costs associated with building and maintaining proton therapy facilities, including equipment and specialized personnel, create financial barriers for many hospitals. Additionally, the limited number of clinical studies and long treatment times restrict the market's ability to fully penetrate the healthcare industry. Insurance reimbursement policies and varying regulatory standards across regions also pose challenges for market players, requiring strategic investment in educational outreach and policy advocacy.

Market Opportunities:

The Proton Therapy Systems market offers substantial opportunities for growth, driven by ongoing technological advancements, rising demand for minimally invasive treatments, and increasing support for cancer research. With the development of compact and more affordable proton therapy units, smaller healthcare providers can potentially integrate this technology, broadening the market's reach. The growing prevalence of pediatric cancers and other complex tumors opens new avenues for proton therapy, as it minimizes adverse effects. Additionally, partnerships between hospitals, research institutions, and technology firms can support new applications of proton therapy, allowing for its use in more diversified clinical settings. As emerging markets strengthen their healthcare infrastructure, investment in proton therapy systems presents an opportunity for companies aiming to expand their presence globally.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Proton Therapy Systems market globally?
• Which cancer types are most commonly treated with Proton Therapy Systems?
• How are technological advancements influencing the competitive landscape of the Proton Therapy Systems market?
• Who are the key players in the Proton Therapy Systems market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Proton Therapy Systems market?

Competitive Intelligence and Business Strategy:

Leading players in the global Proton Therapy Systems market, including Varian Medical Systems, IBA Proton Therapy, and Mevion Medical Systems, are focusing on technological innovation, cost reduction, and strategic partnerships to enhance market share. These companies invest heavily in R&D to develop compact proton therapy systems that reduce costs and expand access. Collaborations with research institutions, hospitals, and government bodies foster greater adoption and accelerate clinical research in proton therapy. Key players also emphasize improving patient outcomes, sustainability, and quality standards, positioning them for strong market growth and enhanced consumer adoption of proton therapy solutions.

Key Companies Profiled:

• Hitachi Ltd.
• Ion Beam Applications SA
• Mevion Medical Systems
• Mitsubishi Electric Corporation
• ProNova Solutions, LLC
• ProTom International
• Sumitomo Heavy Industries Ltd.
• Varian Medical Systems
• Others

Proton Therapy Systems Industry Segmentation:

By Set up Type

• Single Room
• Multiple Room

By Indication

• Head and Neck Cancer
• Brain Cancer
• Sarcoma
• Pediatric Cancer
• Gastro-intestinal Cancer
• Prostate Cancer
• Lung Cancer

By Region

• North America
• Europe
• Asia pacific
• MEA

Table of Contents

1. Executive Summary

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy

3. Global Proton Therapy Market Analysis Scenario

• 3.1. Market Size (US$ Mn) and Forecast
  • 3.1.1. Market Size and Y-o-Y Growth
  • 3.1.2. Absolute $ Opportunity

4. Market Dynamics

• 4.1. Economic Factors
• 4.2. Drivers
  • 4.2.1. Supply Side
  • 4.2.2. Demand Side
• 4.3. Restraints
• 4.4. Opportunity
• 4.5. Installed Base Data
• 4.6. World Cancer Prevalence

5. Global Proton Therapy Market Analysis and Forecasts, By Set Up Type

• 5.1. Introduction
• 5.2. Basis Point Share (BPS) Analysis By Set Up Type
• 5.3. Y-o-Y Growth Projections By Set Up Type
• 5.4. Market Value Forecast By Set Up Type, 2024-2031
  • 5.4.1. Single Room
  • 5.4.2. Multiple Rooms
• 5.5. Market Attractiveness By Set Up Type

6. Global Proton Therapy Market Analysis and Forecasts, By Indications

• 6.1. Introduction
• 6.2. Basis Point Share (BPS) Analysis By Indications
• 6.3. Y-o-Y Growth Projections By Indications
• 6.4. Market Value Forecast By Indications, 2024-2031
  • 6.4.1. Head & Neck Cancer
  • 6.4.2. Brain Cancer
  • 6.4.3. Sarcoma
  • 6.4.4. Pediatric Cancer
  • 6.4.5. Gastro-intestinal Cancer
  • 6.4.6. Prostate Cancer
  • 6.4.7. Lung Cancer
• 6.5. Market Attractiveness By Indications

7. Global Proton Therapy Market Analysis and Forecasts, By Region

• 7.1. Basis Point Share (BPS) Analysis By Region
• 7.2. Y-o-Y Growth Projections By Region
• 7.3. Market Value Forecast By Region
  • 7.3.1. North America
  • 7.3.2. Europe
  • 7.3.3. APAC
  • 7.3.4. MEA
• 7.4. Market Attractiveness By Region

8. North America Proton Therapy Market Analysis and Forecast

• 8.1. Introduction
  • 8.1.1. Basis Point Share (BPS) Analysis By Country
  • 8.1.2. Y-o-Y Growth Projections By Country
• 8.2. Market Value Forecast By Set Up Type, 2024-2031
  • 8.2.1. Single Room
  • 8.2.2. Multiple Rooms
• 8.3. Market Value Forecast By Indications, 2024-2031
  • 8.3.1. Head & Neck Cancer
  • 8.3.2. Brain Cancer
  • 8.3.3. Sarcoma
  • 8.3.4. Pediatric Cancer
  • 8.3.5. Gastro-intestinal Cancer
  • 8.3.6. Prostrate Cancer
  • 8.3.7. Lung Cancer
• 8.4. Market Value Forecast By Country, 2024-2031
  • 8.4.1. US
• 8.5. Market Attractiveness Analysis
  • 8.5.1. By Set Up Type
  • 8.5.2. By Indications

9. Europe Proton Therapy Market Analysis and Forecast

• 9.1. Introduction
  • 9.1.1. Basis Point Share (BPS) Analysis By Country
  • 9.1.2. Y-o-Y Growth Projections By Country
• 9.2. Market Value Forecast By Set Up Type, 2024-2031
  • 9.2.1. Single Room
  • 9.2.2. Multiple Rooms
• 9.3. Market Value Forecast By Indications, 2024-2031
  • 9.3.1. Head & Neck Cancer
  • 9.3.2. Brain Cancer
  • 9.3.3. Sarcoma
  • 9.3.4. Pediatric Cancer
  • 9.3.5. Gastro-intestinal Cancer
  • 9.3.6. Prostrate Cancer
  • 9.3.7. Lung Cancer
• 9.4. Market Value Forecast By Country, 2024-2031
  • 9.4.1. Prague
  • 9.4.2. France
  • 9.4.3. Switzerland
  • 9.4.4. Italy
  • 9.4.5. Germany
  • 9.4.6. U.K.
  • 9.4.7. Sweden
  • 9.4.8. Russia
• 9.5. Market Attractiveness Analysis
  • 9.5.1. By Set Up Type
  • 9.5.2. By Indications
  • 9.5.3. By Country

10. APAC Proton Therapy Market Analysis and Forecast

• 10.1. Introduction
  • 10.1.1. Basis Point Share (BPS) Analysis By Country
  • 10.1.2. Y-o-Y Growth Projections By Country
• 10.2. Market Value Forecast By Set Up Type, 2024-2031
  • 10.2.1. Single Room
  • 10.2.2. Multiple Rooms
• 10.3. Market Value Forecast By Indications, 2024-2031
  • 10.3.1. Head & Neck Cancer
  • 10.3.2. Brain Cancer
  • 10.3.3. Sarcoma
  • 10.3.4. Pediatric Cancer
  • 10.3.5. Gastro-intestinal Cancer
  • 10.3.6. Prostate Cancer
  • 10.3.7. Lung Cancer
• 10.4. Market Value Forecast By Country, 2024-2031
  • 10.4.1. China
  • 10.4.2. Japan
  • 10.4.3. South Korea
• 10.5. Market Attractiveness Analysis
  • 10.5.1. By Set Up Type
  • 10.5.2. By Indications
  • 10.5.3. By Country

11. MEA Proton Therapy Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Basis Point Share (BPS) Analysis
  • 11.1.2. Y-o-Y Growth Projections
• 11.2. Market Value Forecast By Set Up Type, 2024-2031
  • 11.2.1. Single Room
  • 11.2.2. Multiple Rooms
• 11.3. Market Value Forecast By Indications, 2024-2031
  • 11.3.1. Head & Neck Cancer
  • 11.3.2. Brain Cancer
  • 11.3.3. Sarcoma
  • 11.3.4. Pediatric Cancer
  • 11.3.5. Gastro-intestinal Cancer
  • 11.3.6. Prostate Cancer
  • 11.3.7. Lung Cancer
• 11.4. Market Value Forecast By Country, 2024-2031
  • 11.4.1. South Africa
• 11.5. Market Attractiveness Analysis
  • 11.5.1. By Set Up Type
  • 11.5.2. By Indications

12. Competition Landscape

• 12.1. Competition Dashboard
• 12.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  • 12.2.1. Hitachi Ltd.
  • 12.2.2. Ion Beam Applications SA
  • 12.2.3. Mevion Medical Systems
  • 12.2.4. Mitsubishi Electric Corporation
  • 12.2.5. ProNova Solutions, LLC
  • 12.2.6. ProTom International
  • 12.2.7. Sumitomo Heavy Industries Ltd.
  • 12.2.8. Varian Medical Systems

13. Assumptions and Acronyms Used

14. Research Methodology

관련자료